Share

September 30, 2014; 83 (14) Article

ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort

Kristine S. Alexander, Neil A. Zakai, Sarah Gillett, Leslie A. McClure, Virginia Wadley, Fred Unverzagt, Mary Cushman
First published September 10, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000844
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
819

Share

Article Information

vol. 83 no. 14 1271-1276
DOI: 
https://doi.org/10.1212/WNL.0000000000000844
PubMed: 
25209581
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 17, 2014
  • Accepted in final form July 3, 2014
  • First Published September 10, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Kristine S. Alexander, PhD, MCR,
    2. Neil A. Zakai, MD, MSc,
    3. Sarah Gillett, PhD,
    4. Leslie A. McClure, PhD,
    5. Virginia Wadley, PhD,
    6. Fred Unverzagt, PhD and
    7. Mary Cushman, MD, MSc
  1. Kristine S. Alexander, PhD, MCR,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1)NIH Thrombosis and Hemostasis Training Grant, 5T32HL007594, postdoctoral trainee, 2012-2014

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Neil A. Zakai, MD, MSc,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Circulation 2011- Guest Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH / NHLBI (K08HL096841)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Sarah Gillett, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Leslie A. McClure, PhD,
    5. Scientific Advisory Boards:

    1. (1) NIH/NINDS

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH U01 NS41588, co-I

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Virginia Wadley, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Alzheimer's Association travel expenses for Patient- related Outcomes speaking engagement

    Editorial Boards:

    1. Current Gerontology and Geriatrics Research, editoral board, 2010-present, no compensation Journal of Aging Science, editorial board, 2013-present, no compensation

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Genzyme, a Sanofi Corporation, investigator-initiated grant, PI

    Research Support, Government Entities:

    1. (1)NIH, NO1 HC48047, Co-I, 1989-2013 (2)NIH, U01 NS51488, Co-I, 2007-2017 (3)NIH, R01 NS061846,Co-I, 2008-2013 (4)NIH, P30 AG022838,Co-I,2009-2014 (5)NIH, HHSN268200900047C, Co-I, 2009�2018 (6)NIH, R01 AG021958, Co-I, 2009�2014 (7)NIH, R01 AG039588, Co-I, 2011-2016 (8)NIH, R01 NS080850, Co-I, 2012-2017

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Fred Unverzagt, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1) Neuropsychology, Editorial Board, 2007-present 2) Journal of the International Neuropsychological Society, Editorial Board, 20014-present 3) Current Alzheimer Research, Editorial Board, 2013- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) UCB Pharma 2) Piramal Life Science

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support from Posit Science, Inc., in the form of site licenses for cognitive training programs for investigator-initiated research projects.

    Research Support, Government Entities:

    1. R01 AG045157 R01 AG019181 U01 NS041588 P30 AG10133 UL 1RR025761

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Eli Lilly, Inc.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Consultant and expert witness testimony in medicolegal tort cases.

  7. Mary Cushman, MD, MSc
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. I am an Associate Editor for Journal of Thrombosis and Haemostasis since 2007. I am Senior Geust Editor for Circulation since 2011.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. I have received reesarch support from Amgen for this study, but not this paper, more than two years ago. I receive research support from diaDexus

    Research Support, Government Entities:

    1. I have recevied numerous NIH grants for the study of vascular disease epidemiology, including the grant that funded the REGARDS parent study (from NINDS)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Medicine (K.S.A., N.A.Z., S.G., M.C.) and Pathology (N.A.Z., M.C.), University of Vermont, Burlington; School of Public Health (L.A.M.) and Division of Gerontology, Geriatrics and Palliative Care, Department of Medicine (V.W.), University of Alabama at Birmingham; and Department of Psychiatry (F.U.), Indiana University School of Medicine, Indianapolis.
  1. Correspondence to Dr. Cushman: mary.cushman{at}uvm.edu
View Full Text

Article usage

Article usage: September 2014 to May 2022

AbstractFullPdfSource
Sep 2014163177226Highwire
Oct 201432251733Highwire
Nov 201475369Highwire
Dec 201460545Highwire
Jan 201561836Highwire
Feb 201515451011Highwire
Mar 201560852Highwire
Apr 201540923Highwire
May 201529312Highwire
Jun 201538624Highwire
Jul 201526787Highwire
Aug 201526252Highwire
Sep 201528833Highwire
Oct 201531526Highwire
Oct 201502212pmc
Nov 201532701Highwire
Nov 201501310pmc
Dec 201534113Highwire
Dec 2015052pmc
Jan 201632501Highwire
Jan 2016053pmc
Feb 201626712Highwire
Feb 2016092pmc
Mar 201626303Highwire
Mar 20160315pmc
Apr 201614914Highwire
Apr 20160106pmc
May 201616401Highwire
May 20160103pmc
Jun 201624411Highwire
Jun 2016085pmc
Jul 201640600Highwire
Jul 2016092pmc
Aug 201649300Highwire
Aug 20160308pmc
Sep 201639200Highwire
Sep 20160186pmc
Oct 201639600Highwire
Oct 20160102pmc
Nov 201626602Highwire
Nov 20160214pmc
Dec 201623702Highwire
Dec 2016081pmc
Jan 201736600Highwire
Jan 20170231pmc
Feb 201728801Highwire
Feb 20170233pmc
Mar 201723801Highwire
Mar 20170468pmc
Apr 201728900Highwire
Apr 201782022pmc
May 201729501Highwire
May 201742020pmc
Jun 201714500Highwire
Jun 201721212pmc
Jul 201722500Highwire
Jul 201752228pmc
Aug 201717011Highwire
Aug 201773545pmc
Sep 201721530Highwire
Sep 201733434pmc
Oct 201722101Highwire
Oct 201763335pmc
Nov 201723711Highwire
Nov 201711214pmc
Dec 201724701Highwire
Jan 201828701Highwire
Feb 201832743Highwire
Mar 201827951Highwire
Apr 201828820Highwire
Apr 201894052pmc
May 201828120Highwire
Jun 201832501Highwire
Jun 201841819pmc
Jul 201834110Highwire
Aug 201829301Highwire
Aug 201846771pmc
Sep 201829112Highwire
Oct 201827900Highwire
Nov 201828711Highwire
Dec 201829001Highwire
Jan 201927210Highwire
Feb 201923541Highwire
Mar 201924200Highwire
Apr 201921312Highwire
May 201917231Highwire
Jun 201925211Highwire
Jul 201922322Highwire
Aug 201921011Highwire
Sep 201917800Highwire
Oct 201931440Highwire
Nov 201924900Highwire
Dec 201930711Highwire
Jan 202025510Highwire
Feb 202021200Highwire
Mar 202029900Highwire
Apr 202034243Highwire
May 202019700Highwire
Jun 202026500Highwire
Jul 202015100Highwire
Aug 202022000Highwire
Sep 202016330Highwire
Oct 202018800Highwire
Nov 202011510Highwire
Dec 202031932Highwire
Jan 202110332Highwire
Feb 20219312Highwire
Mar 202110010Highwire
Apr 202113001Highwire
May 202110320Highwire
Jun 202110500Highwire
Jul 202115520Highwire
Aug 20219000Highwire
Sep 202112001Highwire
Oct 20218710Highwire
Nov 202131132Highwire
Dec 202126210Highwire
Jan 202218711Highwire
Feb 202216300Highwire
Mar 202219332Highwire
Apr 202212612Highwire
May 20229110Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me